GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innogene Co Ltd (XKRX:344860) » Definitions » EV-to-FCF

Innogene Co (XKRX:344860) EV-to-FCF : 14.68 (As of Apr. 16, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Innogene Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Innogene Co's Enterprise Value is ₩11,878 Mil. Innogene Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₩809 Mil. Therefore, Innogene Co's EV-to-FCF for today is 14.68.

The historical rank and industry rank for Innogene Co's EV-to-FCF or its related term are showing as below:

XKRX:344860' s EV-to-FCF Range Over the Past 10 Years
Min: -276.02   Med: 10.06   Max: 573.85
Current: 15.34

During the past 7 years, the highest EV-to-FCF of Innogene Co was 573.85. The lowest was -276.02. And the median was 10.06.

XKRX:344860's EV-to-FCF is ranked worse than
66.52% of 457 companies
in the Biotechnology industry
Industry Median: 2.23 vs XKRX:344860: 15.34

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-16), Innogene Co's stock price is ₩2115.00. Innogene Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩79.000. Therefore, Innogene Co's PE Ratio (TTM) for today is 26.77.


Innogene Co EV-to-FCF Historical Data

The historical data trend for Innogene Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innogene Co EV-to-FCF Chart

Innogene Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial 1.66 15.94 60.15 9.03 5.58

Innogene Co Quarterly Data
Dec18 Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.03 7.29 12.62 22.68 5.58

Competitive Comparison of Innogene Co's EV-to-FCF

For the Biotechnology subindustry, Innogene Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innogene Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innogene Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Innogene Co's EV-to-FCF falls into.


;
;

Innogene Co EV-to-FCF Calculation

Innogene Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=11878.171/809.153
=14.68

Innogene Co's current Enterprise Value is ₩11,878 Mil.
Innogene Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩809 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innogene Co  (XKRX:344860) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Innogene Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2115.00/79.000
=26.77

Innogene Co's share price for today is ₩2115.00.
Innogene Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩79.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Innogene Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Innogene Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Innogene Co Business Description

Traded in Other Exchanges
N/A
Address
No. 301, 28, Digital-ro 33-gil, Guro-gu, Seoul, KOR
Innogene Co Ltd is a bio-technology company. The company provides treatment solutions using stem cells and databases for hair loss, psoriasis, skin regeneration and hair follicle formation. Also, the company helps in hair loss diagnosis.

Innogene Co Headlines

No Headlines